Trials / Completed
CompletedNCT01439399
Analgesic Efficacy of Intravenous Lidocaine and/or Ketamine
Analgesic Efficacy of Intravenous Perfusion of Lidocaine, Ketamine or a Combination After Laparotomy in a Placebo-controlled, Randomized, Double-blind Prospective Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- University of Lausanne Hospitals · Academic / Other
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the present study is to evaluate the analgesic benefit of intravenous lidocaine and ketamine in the perioperative period of abdominal surgery.
Detailed description
Optimal postoperative pain management facilitates rehabilitation immediately after abdominal surgery. Multiple studies have demonstrated that successful postoperative analgesia also reduces perioperative complications and improves patient comfort, thereby providing many benefits for the patient. In acute postoperative pain management intravenous lidocaine and/or ketamine have been advocated because of their morphine-sparing effect.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lidocaine, | Lidocaine group received an IV bolus of 1.5 mg.kg-1 followed by a continuous infusion of 2 mg.kg-1.h-1 intraoperative and 1.33 mg.kg-1.h-1 for 48 h postoperative. |
| DRUG | Ketamine | Ketamine group received a bolus of 0.5 mg.kg-1, then 0.25 mg.kg-1.h-1 followed by 0.1 mg.kg-1.h-1 for the first 24 h, then 0.05 mg.kg-1.h-1 for the next 24 h. |
| DRUG | association ketamine-lidocaine | Ketamine-lidocaine group received a bolus of 1.5 mg.kg-1 of lidocaine and 0.5 mg.kg-1 of ketamine, a continuous infusion of 1.3 mg.kg-1.h-1 of lidocaine and 0.17 mg.kg-1.h-1 of ketamine was delivered followed by 0.9 mg.kg-1 of lidocaine with 0.08 mg.kg-1.h-1 of ketamine during 48 h, the dose of ketamine being reduced to 0.04 mg.kg-1.h-1 after the first 24 hours. |
| DRUG | Placebo | The control group (C) received an equal volume of saline 0.9 % during 48 h. |
Timeline
- Start date
- 2005-12-01
- Primary completion
- 2007-07-01
- Completion
- 2007-07-01
- First posted
- 2011-09-23
- Last updated
- 2011-09-23
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT01439399. Inclusion in this directory is not an endorsement.